In the original article, there was a mistake in the legend for Figure 1 as published. “(B) Representative images of skin manifestation at day 7 in mice treated with MC903 and treated with vaseline or 1% difamilast.” The correct legend appears below.
“(B) Representative clinical skin manifestation at 0 week (before) and 1 week (after) in patients with AD treated with 1% difamilast.”
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Summary
Keywords
retrospective study, atopic dermatitis, Japanese, difamilast, barrier dysfunction
Citation
Uchiyama A, Taivanbat B, Kosaka K, Ishikawa M, Uehara A, Shimaoka M, Ryuzaki K and Motegi S-I (2026) Corrigendum: The possible effectiveness of difamilast in improving barrier dysfunction in patients with atopic dermatitis and in mouse model. J. Cutan. Immunol. Allergy 9:16328. doi: 10.3389/jcia.2026.16328
Received
30 January 2026
Accepted
04 February 2026
Published
20 February 2026
Volume
9 - 2026
Updates
Copyright
© 2026 Uchiyama, Taivanbat, Kosaka, Ishikawa, Uehara, Shimaoka, Ryuzaki and Motegi.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Akihiko Uchiyama, akihiko1016@gunma-u.ac.jp
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.